Skip to content

Bellipharma: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Bellipharma

BE 0844.039.461
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€9,471
2024 · -€19,063+€9,592
Equity
€214,395
2024 · €223,865-€9,471
Cash
€57,555
2024 · €44,182+€13,373
Balance sheet total
€718,811
2024 · €448,286+€270,524

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€145,143

    up €145,143 (+72.5%), from €200,087 to €345,229

    of which Other tangible fixed assets: +€133,119

  • Stocks and contracts +€83,151

    up €83,151 (+67.4%), from €123,306 to €206,457

  • Receivables within one year +€58,128

    up €58,128 (+113.0%), from €51,441 to €109,569

    of which Trade receivables: +€63,834

  • Intangible fixed assets -€29,270

    down €29,270 (-100.0%), from €29,270 to €0

  • Cash +€13,373

    up €13,373 (+30.3%), from €44,182 to €57,555

    mainly Trade debts (+€115,650) and Current portion of long-term debt (+€106,186)

Equity and liabilities
  • Trade debts +€115,650

    up €115,650 (+668.2%), from €17,308 to €132,958

  • Current portion of long-term debt +€106,186

    up €106,186, from €0 to €106,186

  • Debts after one year +€66,808

    up €66,808, from €0 to €66,808

  • Profit (loss) carried forward -€9,471

    down €9,471 (-21.9%), from €43,265 to €33,795

Income statement
  • Gross operating margin +€124,069

    up €124,069 (+437.2%), from €28,379 to €152,448

  • Staff costs +€81,311

    up €81,311 (+343.8%), from €23,651 to €104,962

  • Depreciation +€5,320

    up €5,320 (+27.0%), from €19,682 to €25,002

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€19,063
Gross operating margin +€124,069
Staff costs -€81,311
Depreciation -€5,320
Other operating items -€29,270
Financial income -€250
Financial charges +€1,461
Taxes +€213
Result 2025 -€9,471

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€18,746
Investment -€140,874
Financing +€172,994
Cash 2024 €44,182
Net result for the year -€9,471
Depreciation +€25,002
Stocks and contracts -€83,151
Receivables within one year -€58,128
Trade debts +€115,650
Tax, wage and social debts -€2,727
Other debts -€5,922
Investment in fixed assets (net) -€140,874
Debts after one year +€66,808
Current portion of long-term debt +€106,186
Cash 2025 €57,555
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €448,286 €718,811 +€270,524 +60.3%
Fixed assets 21/28 €229,357 €345,229 +€115,872 +50.5%
Intangible fixed assets 21 €29,270 €0 -€29,270 -100.0%
Tangible fixed assets 22/27 €200,087 €345,229 +€145,143 +72.5%
Furniture and vehicles 24 - €12,024 +€12,024
Other tangible fixed assets 26 €200,087 €333,206 +€133,119 +66.5%
Current assets 29/58 €218,929 €373,582 +€154,652 +70.6%
Stocks and contracts in progress 3 €123,306 €206,457 +€83,151 +67.4%
Stocks 30/36 €123,306 €206,457 +€83,151 +67.4%
Amounts receivable within one year 40/41 €51,441 €109,569 +€58,128 +113.0%
Trade receivables 40 €41,441 €105,275 +€63,834 +154.0%
Other amounts receivable 41 €10,000 €4,294 -€5,706 -57.1%
Cash at bank and in hand 54/58 €44,182 €57,555 +€13,373 +30.3%
Total equity and liabilities 10/49 €448,286 €718,811 +€270,524 +60.3%
Equity 10/15 €223,865 €214,395 -€9,471 -4.2%
Contributions 10/11 €180,600 €180,600 = 0.0%
Profit (loss) carried forward 14 €43,265 €33,795 -€9,471 -21.9%
Amounts payable 17/49 €224,421 €504,416 +€279,995 +124.8%
Amounts payable after more than one year 17 €0 €66,808 +€66,808
Financial debts 170/4 €0 €66,808 +€66,808
Amounts payable within one year 42/48 €224,421 €437,608 +€213,187 +95.0%
Current portion of amounts payable after more than one year 42 €0 €106,186 +€106,186
Trade debts 44 €17,308 €132,958 +€115,650 +668.2%
Suppliers 440/4 €17,308 €132,958 +€115,650 +668.2%
Taxes, remuneration and social security 45 €2,727 €0 -€2,727 -100.0%
Taxes 450/3 €0 - =
Remuneration and social security 454/9 €2,727 €0 -€2,727 -100.0%
Other amounts payable 47/48 €204,387 €198,464 -€5,922 -2.9%
Non-recurring operating income 76A €0 €199 +€199
Remuneration, social security and pensions 62 €23,651 €104,962 +€81,311 +343.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €19,682 €25,002 +€5,320 +27.0%
Non-recurring operating charges 66A - €29,270 +€29,270
Gross operating margin 9900 €28,379 €152,448 +€124,069 +437.2%
Operating profit (loss) 9901 -€14,954 -€6,786 +€8,168 +54.6%
Financial income 75/76B €250 €0 -€250 -100.0%
Recurring financial income 75 €250 €0 -€250 -100.0%
Financial charges 65/66B €4,146 €2,684 -€1,461 -35.3%
Recurring financial charges 65 €4,146 €2,684 -€1,461 -35.3%
Profit (loss) for the period before taxes 9903 -€18,850 -€9,471 +€9,379 +49.8%
Income taxes 67/77 €213 €0 -€213 -100.0%
Profit (loss) for the period 9904 -€19,063 -€9,471 +€9,592 +50.3%
Profit (loss) for the period to be appropriated 9905 -€19,063 -€9,471 +€9,592 +50.3%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 September 2026 via checked.be.